Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

4 Incredible Dividend Stocks Yielding 4%-Plus to Buy in 2024


Dividend stocks can be incredible investments. They've historically outperformed the market over the long term. The best returns have come from companies that routinely increase their dividends.

Dividend growers also tend to deliver better returns in flat to slightly higher markets. That could be what's in store in 2024 following the market's massive rally in 2023. Four exceptional Dividend stocks are (NYSE: ABBV), Brookfield Renewable (NYSE: BEPC)(NYSE: BEP), Realty Income (NYSE: O), and T. Rowe Price (NASDAQ: TROW). They all offer dividends yielding 4% or more (more than double the S 500's 1.5% yield) that should continue rising in 2024.

AbbVie's dividend yield is right around 4%. The healthcare company has an excellent track record of growing that payout. It has increased its dividend every year since its inception in 2023, including already unveiling plans to lift it by another 4.7% for 2024. With that increase, AbbVie has boosted its payout by 285% since its formation.

Continue reading


Source Fool.com

AbbVie Inc. Aktie

171,48 €
-2,48 %
Heute verliert die AbbVie Inc. Aktie an Boden, ein Rückgang von -2,48 %.
Einzigartige Zustimmung für AbbVie Inc. mit ausschließlich Buy-Einschätzungen.
Ein positives Kurspotenzial für AbbVie Inc. ist gegeben, mit einem Kursziel von 180 € über dem aktuellen Kurs von 171.48 €.
Like: 0
Teilen

Kommentare